Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack ...

The updated guidance, published March 13 in the Journal of the American College of Cardiology (JACC) and Circulation, replaces the 2018 cholesterol guidelines and reflects a major shift in how doctors ...

The update was jointly published in the journal Circulation and the Journal of the American College of Cardiology. The recent guideline is retitled the 2026 Guideline on the Management of Dyslipidemia ...

New guidelines recommend considering cholesterol-lowering statins in the 30s, screening all adults for hidden risk factors ...

Based on a 2020 study published Journal of the American Society of Nephrology, National Kidney Foundation, and American Heart Association guidelines. Protein is essential for building muscle, but too ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.

The ACC and AHA released updated guidelines for the management of dyslipidemia to reduce risk for atherosclerotic cardiovascular disease.

Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and ...

For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...